Chemistry:Para-Chlorophenethylamine

From HandWiki
Short description: Chemical compound

para-Chlorophenethylamine
Clinical data
Drug classserotonergic agent; serotonin-releasing agent; monoaminergic neurotoxin
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC8H10ClN
Molar mass155.63 g·mol−1
3D model (JSmol)

para-Chlorophenethylamine (pCPE) also known as 4-chlorophenylethylamine, is a potent serotonergic drug that is a structural analog of para-chloroamphetamine, lacking a methyl group at the α-position.

Pharmacology

Pharmacodynamics

para-Chlorophenethylamine acts primarily as a serotonin-releasing agent with an EC50 value of 430 nM for the serotonin transporter, approximately the dose required to induce serotonin syndrome with seizures, tremor, and hyperthermia in mice, is quite low compared to other derivatives (such as ortho-chlorophenethylamine and meta-chlorophenethylamine)[1][2] In mice with serotonin syndrome induced by para-chlorophenethylamine, the following symptoms were observed: lateral head bobbing, a Straub tail reaction, abduction of the hind limbs, tremors, hyperactivity, mutual pawing with the front paws, salivation, and piloerection.[3] It acts as a full, weak agonist of TAAR with an EC50 value of 2,900 ± 1,000 nM.[4]

In vitro, it inhibited the activity of the enzyme phenylethanolamine N-methyltransferase.[5] Para-chlorophenelethylamine stimulated 5-HT receptors.[3][6]

Pharmacokinetics

para-Chlorophenethylamine is a known metabolite of the para-chlorophenylalanine (fenclonine); it rapidly accumulated in the brain following administration of fenclonine.[7]

Drug control

Para-chlorophenylethylamine is a controlled substance in Hungary, classified under the category “New Psychoactive Substances[8]

See also

References

  1. "Comparative effects of substituted phenylethylamines on brain serotonergic mechanisms". The Journal of Pharmacology and Experimental Therapeutics 213 (2): 254–260. May 1980. doi:10.1016/S0022-3565(25)32053-7. PMID 6965983. 
  2. "Comparative effects of various serotonin releasing agents in mice". Biochemical Pharmacology 29 (23): 3163–3167. December 1980. doi:10.1016/0006-2952(80)90580-8. PMID 6449931. 
  3. 3.0 3.1 "Behavioral and biochemical actions of p-chlorophenylethylamine (p-CPEA) in mice". Life Sciences 24 (7): 595–601. February 1979. doi:10.1016/0024-3205(79)90155-3. PMID 155767. 
  4. "Structure-activity correlations for beta-phenethylamines at human trace amine receptor 1". Bioorganic & Medicinal Chemistry 16 (15): 7415–7423. August 2008. doi:10.1016/j.bmc.2008.06.009. PMID 18602830. 
  5. "Possible resolution of a paradox concerning the use of p-chlorophenylalanine and 5-hydroxytryptophan: evidence for a mode of action involving adrenaline in manipulating the surge of luteinizing hormone in rats". Neuroscience 8 (3): 583–591. March 1983. doi:10.1016/0306-4522(83)90200-2. PMID 6222267. 
  6. "Para-halogenated phenethylamines: similar serotonergic effects in rats by different mechanisms". Pharmacology, Biochemistry, and Behavior 13 (2): 283–286. August 1980. doi:10.1016/0091-3057(80)90084-2. PMID 6447879. 
  7. "Para-chlorophenylethylamine in brains of rats treated with a monoamine oxidase inhibitor and p-chlorophenylalanine". Progress in Neuro-Psychopharmacology & Biological Psychiatry 6 (4–6): 343–346. 1982. doi:10.1016/s0278-5846(82)80103-6. PMID 6219431. 
  8. "78/2022. (XII. 28.) BM rendelet - Nemzeti Jogszabálytár". https://njt.hu/jogszabaly/2022-78-20-0A. 

Template:Monoaminergic neurotoxins